Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection
Eleanor C. Semmes, Itzayana G. Miller, Courtney E. Wimberly, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 16
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine
Xintao Hu, Krithika P. Karthigeyan, Savannah Herbek, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 2, pp. 455-466
Closed Access | Times Cited: 27
Maternal immune protection against infectious diseases
Stephanie N. Langel, Maria Blasi, Sallie R. Permar
Cell Host & Microbe (2022) Vol. 30, Iss. 5, pp. 660-674
Open Access | Times Cited: 46
Protective mechanisms of nonneutralizing antiviral antibodies
T.L. Chandler, Agnes Yang, Claire E. Otero, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 10, pp. e1011670-e1011670
Open Access | Times Cited: 28
Safety, efficacy, and immunogenicity of a replication-defective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: a double-blind, randomised, placebo-controlled, phase 2b trial
Rituparna Das, Daniel Blázquez‐Gamero, David I. Bernstein, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 12, pp. 1383-1394
Closed Access | Times Cited: 26
ADCC-activating antibodies correlate with decreased risk of congenital human cytomegalovirus transmission
Eleanor C. Semmes, Itzayana G. Miller, Nicole Rodgers, et al.
JCI Insight (2023) Vol. 8, Iss. 13
Open Access | Times Cited: 23
A vaccine against cytomegalovirus: how close are we?
Sallie R. Permar, Mark R. Schleiss, S. A. Plotkin
Journal of Clinical Investigation (2025) Vol. 135, Iss. 1
Closed Access | Times Cited: 1
Rhesus Cytomegalovirus-encoded Fcγ-binding glycoproteins facilitate viral evasion from IgG-mediated humoral immunity
Claire E. Otero, Sophia Petkova, Martin Ebermann, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Characterization of humoral and cellular immunologic responses to an mRNA-based human cytomegalovirus vaccine from a phase 1 trial of healthy adults
Kai Wu, Yixuan J. Hou, Dan Makrinos, et al.
Journal of Virology (2024) Vol. 98, Iss. 4
Open Access | Times Cited: 8
Decidual-tissue-resident memory T cells protect against nonprimary human cytomegalovirus infection at the maternal-fetal interface
Or Alfi, Mevaseret Cohen, Shikma Bar-On, et al.
Cell Reports (2024) Vol. 43, Iss. 2, pp. 113698-113698
Open Access | Times Cited: 7
Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation
Madeline R. Sponholtz, Patrick O. Byrne, Alison G. Lee, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 37
Open Access | Times Cited: 6
Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth
Hsuan-Yuan Wang, Leike Li, Cody S. Nelson, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Lessons from Acquired Natural Immunity and Clinical Trials to Inform Next-Generation Human Cytomegalovirus Vaccine Development
Xintao Hu, Hsuan-Yuan Wang, Claire E. Otero, et al.
Annual Review of Virology (2022) Vol. 9, Iss. 1, pp. 491-520
Open Access | Times Cited: 22
Relationship of maternal cytomegalovirus-specific antibody responses and viral load to vertical transmission risk following primary maternal infection in a rhesus macaque model
Claire E. Otero, Richard Barfield, Elizabeth A. Scheef, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 10, pp. e1011378-e1011378
Open Access | Times Cited: 11
Proceedings of the Conference “CMV Vaccine Development—How Close Are We?” (27–28 September 2023)
Mark R. Schleiss, Chelsea M. Crooks, Krithika P. Karthigeyan, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1231-1231
Open Access | Times Cited: 4
Human cytomegalovirus gH/gL/gO binding to PDGFRα provides a regulatory signal activating the fusion protein gB that can be blocked by neutralizing antibodies.
Eric P. Schultz, Lars Ponsness, Jean-Marc Lanchy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Porcine antibodies reveal novel non-neutralizing universal epitopes on FMDV and their overlaps with neutralization sites
Ying Sun, Shenglin Huang, Fengjuan Li, et al.
Veterinary Microbiology (2025) Vol. 303, pp. 110440-110440
Closed Access
Influence of Distinct Maternal Cytomegalovirus-Specific Neutralizing and Fc Receptor-Binding Responses on Congenital Cytomegalovirus Transmission in HIV-Exposed Neonates
Itzayana G. Miller, Aakash Mahant Mahant, Jennifer A. Jenks, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 325-325
Open Access
The pentameric complex is not required for congenital CMV transmission in seronegative rhesus macaques
Hsuan-Yuan Wang, Husam Taher, Craig N. Kreklywich, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 789
Closed Access
Human cytomegalovirus gH/gL/gO binding to PDGFRα provides a regulatory signal activating the fusion protein gB that can be blocked by neutralizing antibodies
Eric P. Schultz, Lars Ponsness, Jean-Marc Lanchy, et al.
Journal of Virology (2025)
Open Access
Developing a Vaccine Against Human Cytomegalovirus: Identifying and Targeting HCMV’s Immunological Achilles’ Heel
Anastasia Lankina, Marta Brezmes Raposo, Alexander Hargreaves, et al.
Vaccines (2025) Vol. 13, Iss. 5, pp. 435-435
Open Access
Selective decoupling of IgG1 binding to viral Fc receptors restores antibody-mediated NK cell activation against HCMV
Ahlam N. Qerqez, Katja Hoffmann, Alison G. Lee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Diverging Maternal and Cord Antibody Functions From SARS-CoV-2 Infection and Vaccination in Pregnancy
Emily H. Adhikari, Pei Lu, Ye jin Kang, et al.
The Journal of Infectious Diseases (2023) Vol. 229, Iss. 2, pp. 462-472
Open Access | Times Cited: 10
Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation
Madeline R. Sponholtz, Patrick O. Byrne, Alison G. Lee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Rhesus Cytomegalovirus-encoded Fcγ-binding glycoproteins facilitate viral evasion from IgG-mediated humoral immunity
Claire E. Otero, Sophia Petkova, Martin Ebermann, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses than that of the Partially Effective gB/MF59 Vaccine
Xintao Hu, Krithika P. Karthigeyan, Savannah Herbek, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top